Global Cellulite Treatment Market

Market Value•  Global Cellulite Treatment market revenue is expected to expand at impressive CAGR of 7.7%  over the forecast period to reach value of US$ 5,227.7  Mn by 2028 end
•  In terms of revenue, Non-invasive treatment procedure segment is projected to remain the dominant it is expected to gain traction due to high demand from specialized dermatology clinics  and hospitals
•  Soft cellulite segment is expected to gain significant market share over the forecast period due to high number of obesity population
•  Among all end users, Specialized dermatology clinics dominated the global market by 50.1% share in 2018
•  North America is considered to be a lucrative marketplace for the global cellulite treatment market and estimated to retain over 39.8% (2018) of the global market share during 2018–2028

Macro-economic Factors:

•  Increasing Cosmetic Surgery Procedures
•  Rise In Global Annual Disposable Income Per Capita

Drivers:

•  Increasing self awareness among the consumers
•  Rising prevalence of fat deposition related disorders requiring better treatment options

Trends:

•  Increasing preference for non-surgical procedures in U.S., the largest market
•  Increasing inclination towards aesthetic procedures

Competitive Landscape:

•  Merz Pharma GmbH & Co. KGaA
•  Cynosure, Inc. (Sub. Hologic Inc.)
•  Tanceuticals, LLC.
•  Inceler Medikal Co. Ltd.
•  Cymedics
•  Nubway
•  Zimmer Aesthetics
•  Syneron Medical Inc

Share By Treatment

Overall Market Approach:

•  Research collaborations and partnerships between research institutes and technology companies is the prominent trend observed in global cellulite treatment market
•  Adoption of newer marketing strategy by device manufacturers to attract problem suffering population effecting with normal requirement of these devices at lower price

FMI

Key Segments:

•  Non-Invasive segment contributed highest market share and will continue to do so due to focused development of Rising prevalence of fat deposition related disorders requiring better treatment options
•  Development of topical treatment would have higher impact on penetration

Target Country:

•  The U.S. being highly growth market and possess expertise and resources, is expected to continue to dominate the global market
•  Majority of manufacturers of cellulite treatment are focusing to launch their product in emerging market due to chances of early approval that by FDA  

Differentiating Strategy:

•  Manufacturers of cellulite treatment are focusing to raise capital required for launch of new products or research and development expenses through venture financing
•  Company are also resorting to hiring of CMOs and CDMOs in order to reduce operational costs and improve overall productivity

Wheel Of Fortune

 

 

Source: futuremarketinsights.com

Harvard Medical School - SEAL Program Medical Taiwan International Medical, Health & Care Expo Greiner Bio-One -Preanalytics